94 related articles for article (PubMed ID: 12870023)
21. Construction and immunogenicity of human papillomavirus type 6b L1 recombinant plasmid.
Liu F; Wang JB; Zuo YG; Liu YH; Ma DL
Chin Med Sci J; 2004 Sep; 19(3):233-6. PubMed ID: 15506656
[TBL] [Abstract][Full Text] [Related]
22. DNA vaccine against human papillomavirus type 16: modifications of the E6 oncogene.
Poláková I; Pokorná D; Dusková M; Smahel M
Vaccine; 2010 Feb; 28(6):1506-13. PubMed ID: 20003917
[TBL] [Abstract][Full Text] [Related]
23. [Reversal effect of antisense RNA targeting human papillomavirus 16 (HPV16) E6E7 on malignancy of human cervical cancer cell line SiHa].
Sima N; Wang W; Xu Q; Tian X; Luo AY; Lu YP; Wang SX; Ma D
Ai Zheng; 2007 Jan; 26(1):26-31. PubMed ID: 17222363
[TBL] [Abstract][Full Text] [Related]
24. Immune response to plasmid DNA encoding HPV16-L1 protein.
Sun X; Si L; Cao Z; Wang Y; Liu T; Guo J
Chin Med J (Engl); 2000 Mar; 113(3):277-80. PubMed ID: 11775264
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.
Tan TM; Gloss B; Bernard HU; Ting RC
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152
[TBL] [Abstract][Full Text] [Related]
26. E6/E7 expression of human papillomavirus types in cutaneous squamous cell dysplasia and carcinoma in immunosuppressed organ transplant recipients.
Dang C; Koehler A; Forschner T; Sehr P; Michael K; Pawlita M; Stockfleth E; Nindl I
Br J Dermatol; 2006 Jul; 155(1):129-36. PubMed ID: 16792764
[TBL] [Abstract][Full Text] [Related]
27. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
28. [Construction and expression characteristics in vitro of human papillomavirus type 16 E7 suicidal DNA vaccine].
Wang HR; Wang BN; Li WY; Zuo FQ; Li H; Jiang ZH; Shi QF; Li MY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):165-8. PubMed ID: 18630674
[TBL] [Abstract][Full Text] [Related]
29. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
[TBL] [Abstract][Full Text] [Related]
30. Design of a highly effective therapeutic HPV16 E6/E7-specific DNA vaccine: optimization by different ways of sequence rearrangements (shuffling).
Almajhdi FN; Senger T; Amer HM; Gissmann L; Öhlschläger P
PLoS One; 2014; 9(11):e113461. PubMed ID: 25422946
[TBL] [Abstract][Full Text] [Related]
31. A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity.
Lin CT; Tsai YC; He L; Calizo R; Chou HH; Chang TC; Soong YK; Hung CF; Lai CH
J Biomed Sci; 2006 Jul; 13(4):481-8. PubMed ID: 16649071
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of 70 kD heat shock protein in cultured primary human keratinocytes induced by human papillomavirus 16 E6/E7 gene.
Liao WJ; Fan PS; Fu M; Fan XL; Liu YF
Chin Med J (Engl); 2005 Dec; 118(24):2058-62. PubMed ID: 16438903
[TBL] [Abstract][Full Text] [Related]
33. Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.
Oosterhuis K; Ohlschläger P; van den Berg JH; Toebes M; Gomez R; Schumacher TN; Haanen JB
Int J Cancer; 2011 Jul; 129(2):397-406. PubMed ID: 21207427
[TBL] [Abstract][Full Text] [Related]
34. [Cloning and expressing of human papillomavirus 16 E7C subgene].
Xu J; Si J; Song G; Liu S; Li K
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):373-8. PubMed ID: 12567436
[TBL] [Abstract][Full Text] [Related]
35. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene.
Vousden KH; Doniger J; DiPaolo JA; Lowy DR
Oncogene Res; 1988 Sep; 3(2):167-75. PubMed ID: 2852339
[TBL] [Abstract][Full Text] [Related]
36. [Study of immune responses induced by human papillomavirus type 18 L1-E6 and L1-E7 chimeric gene DNA vaccines in mice].
Li A; Yang J; Lai BC; Geng YP; Wang Y; Wang YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):760-3. PubMed ID: 15555456
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
Peto M; Tolle-Ersü I; Kreysch HG; Klock G
J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
[TBL] [Abstract][Full Text] [Related]
38. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
[TBL] [Abstract][Full Text] [Related]
39. [Expression, purification, and serum antibody detection of HPV16 E6 in cervical cancer patients].
Gao YE; Guo JZ; Zhang J; Song TB; Yan XJ
Ai Zheng; 2006 Nov; 25(11):1374-9. PubMed ID: 17094904
[TBL] [Abstract][Full Text] [Related]
40. Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins.
Pozzi E; Basavecchia V; Zanotto C; Pacchioni S; Morghen Cde G; Radaelli A
J Virol Methods; 2009 Jun; 158(1-2):184-9. PubMed ID: 19428588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
